Related Experiment Video

Updated: Aug 8, 2026

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

Gene therapy approaches for the management of non-small cell lung cancer

J A Roth1, S F Grammer, S G Swisher

  • 1Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

Seminars in Oncology
|October 18, 2001
PubMed

Insights

Gene therapy using wild-type p53 shows promise for lung cancer by targeting genetic defects. Further research is needed to improve delivery systems and combination strategies for better clinical success.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Targeting cancer-driving genetic mutations offers a path to more effective therapies with reduced toxicity.
  • Restoring tumor suppressor gene pathways, particularly p53, is a key strategy in lung cancer treatment.
  • Adenoviral vector delivery of wild-type p53 has been extensively studied in clinical trials.

Purpose of the Study:

  • To review the current state and challenges of cancer gene therapy.
  • To highlight recent advancements in gene therapy for non-small cell lung cancer.
  • To explore potential improvements for clinical success.

Main Methods:

  • Review of clinical trials and scientific literature on p53 gene therapy for lung cancer.
  • Analysis of gene transduction, expression, apoptosis induction, and clinical responses.
  • Examination of novel strategies like improved delivery, bystander effects, and combination therapies.

Main Results:

  • Clinical trials demonstrate successful gene transduction and expression of p53.
  • Evidence of apoptosis induction and clinical responses, including complete pathologic responses, has been observed.
  • Current approaches require further refinement for widespread clinical application.

Conclusions:

  • Gene therapy, specifically p53 replacement, shows therapeutic potential in lung cancer.
  • Improvements in gene delivery, bystander effects, and combination treatments are crucial.
  • Further research and refinement are necessary to optimize gene therapy for clinical success in non-small cell lung cancer.

More Related Videos

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.